Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-κB pathway through microbiota–gut–brain axis

Parkinson's disease (PD) is the second most common neurodegenerative disease, but none of the current treatments for PD can halt the progress of the disease due to the limited understanding of the pathogenesis. In PD development, the communication between the brain and the gastrointestinal syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhe, Li, Fangyuan, Ning, Jingwen, Peng, Ran, Shang, Junmei, Liu, Hui, Shang, Meiyu, Bao, Xiu-Qi, Zhang, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463266/
https://www.ncbi.nlm.nih.gov/pubmed/34589401
http://dx.doi.org/10.1016/j.apsb.2021.03.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463266/
https://www.ncbi.nlm.nih.gov/pubmed/34589401
http://dx.doi.org/10.1016/j.apsb.2021.03.020

Ejemplares similares